519 related articles for article (PubMed ID: 10593131)
21. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis.
Wiersinga WM; Poppe KG; Effraimidis G
Lancet Diabetes Endocrinol; 2023 Apr; 11(4):282-298. PubMed ID: 36848916
[TBL] [Abstract][Full Text] [Related]
22. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
[TBL] [Abstract][Full Text] [Related]
23. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
24. Treatment options for hyperthyroidism.
Wartofsky L
Hosp Pract (1995); 1996 Sep; 31(9):69-73, 76-8, 81-4. PubMed ID: 8814121
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment].
Véliz J; Pineda G; Arancibia P; Wohllk N
Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059
[TBL] [Abstract][Full Text] [Related]
26. Hyperthyroidism. Current treatment guidelines.
Gittoes NJ; Franklyn JA
Drugs; 1998 Apr; 55(4):543-53. PubMed ID: 9561343
[TBL] [Abstract][Full Text] [Related]
27. Hyperthyroidism.
Chaker L; Cooper DS; Walsh JP; Peeters RP
Lancet; 2024 Feb; 403(10428):768-780. PubMed ID: 38278171
[TBL] [Abstract][Full Text] [Related]
28. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
[TBL] [Abstract][Full Text] [Related]
29. Current approach to surgical management of hyperthyroidism.
Barczyński M
Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):124-131. PubMed ID: 33494587
[TBL] [Abstract][Full Text] [Related]
30. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.
Träisk F; Tallstedt L; Abraham-Nordling M; Andersson T; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Ponjavic V; Taube A; Törring O; Wallin G; Asman P; Lundell G;
J Clin Endocrinol Metab; 2009 Oct; 94(10):3700-7. PubMed ID: 19723755
[TBL] [Abstract][Full Text] [Related]
31. [Prevention and multimodal therapy of hyperthyroidism].
Palitzsch KD
Internist (Berl); 2008 Dec; 49(12):1428, 1430-2, 1434-6. PubMed ID: 18946641
[TBL] [Abstract][Full Text] [Related]
32. Evaluation and Management of Children with Thyrotoxicosis.
Leung AKC; Leung AAC
Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552
[TBL] [Abstract][Full Text] [Related]
33. [Toxic multinodular goiter].
Fukada S
Nihon Rinsho; 2006 Dec; 64(12):2227-32. PubMed ID: 17154083
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
35. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
[TBL] [Abstract][Full Text] [Related]
37. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study.
Chouhan A; Abhyankar A; Basu S
Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and management of large toxic multinodular goiters.
Hamburger JI; Hamburger SW
J Nucl Med; 1985 Aug; 26(8):888-92. PubMed ID: 2411889
[TBL] [Abstract][Full Text] [Related]
39. Early changes of thyroid hormone concentrations after (131)I therapy in Graves' patients pretreated or not with methimazole.
Pirnat E; Zaletel K; Gaberscek S; Fidler V; Hojker S
Nuklearmedizin; 2004 Aug; 43(4):129-34. PubMed ID: 15316580
[TBL] [Abstract][Full Text] [Related]
40. Serum thyroglobulin in normal subjects and patients with hyperthyroidism due to Graves' disease: effects of T3, iodide, 131I and antithyroid drugs.
Gardner DF; Rothman J; Utiger RD
Clin Endocrinol (Oxf); 1979 Dec; 11(6):585-94. PubMed ID: 93993
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]